Bioleaper was founded in 2020 and is headquartered in Shanghai, operating approximately 2,000 square meters of biological laboratory space, 2,000 square meters of chemical analysis laboratories, and 800 square meters of chemical synthesis facilities. The company’s product portfolio comprises biological and biochemical reagents, detection kits, and laboratory consumables supporting applications in molecular biology, protein analysis and immunoassays, as well as tissue, cell, and microbiology research.
